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The Orphan Disease Networks
Minlu Zhang,1,3,5 Cheng Zhu,1,5 Alexis Jacomy,4 Long J. Lu,1,2,3 and Anil G. Jegga1,2,3,*
The low prevalence rate of orphan diseases (OD) requires special combined efforts to improve diagnosis, prevention, and discovery of
novel therapeutic strategies. To identify and investigate relationships based on shared genes or shared functional features, we have con-
ducted a bioinformatic-based global analysis of all orphan diseases with known disease-causing mutant genes. Starting with a bipartite
network of known OD and OD-causing mutant genes and using the human protein interactome, we first construct and topologically
analyze three networks: the orphan disease network, the orphan disease-causing mutant gene network, and the orphan disease-causing
mutant gene interactome. Our results demonstrate that in contrast to the common disease-causing mutant genes that are predomi-
nantly nonessential, a majority of orphan disease-causing mutant genes are essential. In confirmation of this finding, we found that
OD-causing mutant genes are topologically important in the protein interactome and are ubiquitously expressed. Additionally, func-
tional enrichment analysis of those genes in which mutations cause ODs shows that a majority result in premature death or are lethal
in the orthologous mouse gene knockout models. To address the limitations of traditional gene-based disease networks, we also
construct and analyze OD networks on the basis of shared enriched features (biological processes, cellular components, pathways,
phenotypes, and literature citations). Analyzing these functionally-linked OD networks, we identified several additional OD-OD rela-
tions that are both phenotypically similar and phenotypically diverse. Surprisingly, we observed that the wiring of the gene-based
and other feature-based OD networks are largely different; this suggests that the relationship between ODs cannot be fully captured
by the gene-based network alone.Introduction
The US Rare Disease Act of 2002 defined a rare or orphan
disease (OD) as a disease that affects fewer than 200,000
inhabitants, equivalent to approximately 6.5 patients per
10,000 inhabitants.1 There are an estimated 8000 ODs,
many of which are known to be of genetic origin, affect
children at a very early age, and be life-threatening and/or
chronically debilitating.2,3 Orphan diseases exist in all
disease classes and range from exceptionally rare to more
prevalent. Because there are so many ODs and because
each has such a low prevalence, it is difficult to develop
a public health policy specific to each disease. It is possible,
however, to have a global rather than a piecemeal
approach in the areas of OD and orphan drug research
and development, information, and training.4 In the
decade before the US Orphan Drug Act in 1983, only ten
drugs for rare diseases had received FDA marketing
approval, compared with more than 300 orphan drugs
that were subsequently approved.5 Most of these orphan
drugs, however, are for rare cancers or metabolic diseases,
and very few are for ODs of other classes. Furthermore,
most of these are symptomatic therapies rather than
curative or able to modify fundamental pathophysiology.
Additionally, the prices of such approved drugs are in
many cases high and hence are a burden for health insurers
or patients.6
A recent study reports that ODs featured in a high
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publications.7 Previous studies indicate that many human
diseases are interrelated or grouped together due to pertur-
bation of the same gene. Disease networks, disease-causing
mutant gene networks, and drug target networks8–10
are increasingly explored as a complement to networks
centered on protein or gene interactions. However, the
quality of these networks is heavily dependent on the
quantity and quality of information that supports their
creation11 and is also constrained by the number of known
disease-causingmutant genes. One way to overcome this is
to use functional linkages based on features other than
genes alone. Linghu et al.12 used such functional linkages
to identify associations between genes involved in differ-
ent diseases and to identify relationships that might be
associated functionally related sets of genes rather than
with the same genes.
Elucidating the mechanisms and interconnectivity of
most of the 1700 ODs with known disease-causing mutant
genes is important not only for ODs and orphan drug
development but also for the understanding of normal
biological pathways and common diseases. For example,
some of the most effective treatments for coronary artery
disease, a very common disease, were first established
during the study of familial hypercholesterolemia, an
orphan disease. In the current study, using ODs and their
known disease-causingmutant genes,13–15 we built a bipar-
tite graph of the human orphan diseasome to investigate
the ODs and OD-causing mutant genes (ODMG) in the5229, USA; 2Department of Pediatrics, University of Cincinnati, Cincinnati,
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context of shared gene networks, protein interactions,
functional linkages, and literature-based connectivity.Figure 1. Workflow for Generating the OD Networks on the
Basis of Shared Genes or Enriched Functional Features
(A) The details of the ODN, ODMGN, and ODMGI that are gener-
ated with the orphan disease and OD-causing mutant gene bipar-
tite network and the human protein interactome.
(B) Outlines of the method and results of the functionally
connected ODs.Material and Methods
Data Resources and Analysis
The orphan diseases and mutant gene information was down-
loaded from Orphanet13 with the Uniprot Knowledgebase15 inter-
face. We then parsed these 2092 orphan disease terms into 1772
distinct orphan diseases by merging some of the disease subtypes
of a single disease based on their given disorder names as described
previously.9 To compare the ODMGs with common disease genes,
we extracted the current curated list of all known disorder-gene
associations from theMorbidMap of the OnlineMendelian Inher-
itance in Man (OMIM).14 The human protein interactome used in
this study was compiled from several resources16–21 with both
redundant interactions and self-loops removed. We defined essen-
tial genes (n ¼ 2481) as previously described9 by retrieving a list of
humanorthologs ofmouse genes that resulted in lethal phenotype
in embryonic andpostnatal stagesuponknockout (cataloged in the
Mouse Genome database22). The list of ubiquitously expressed
human genes was compiled from Ramskold et al.23 and Tu et al.24
The mitochondrial genes were downloaded from the MitoCarta
database,25 an inventory of mammalian mitochondrial genes. To
identify enriched features (Biological Process,CellularComponent,
Mammalian Phenotype, and pathways), we used the ToppGene
Suite.26 The feature-based OD networks were constructed with
the shared enriched feature (p cut-off 0.05; Bonferroni correction)
as an edge. Literature-based orphan disease networks (ODNs)
were generated with the shared cited literature in the correspond-
ing OMIM14 disease records of the ODs from the Orphanet. The
mappings of OD to OMIM were obtained from the Orphanet.
Two ODs are connected if they have a same article cited in their
respective OMIM disease records (Figure 1).
Analysis of the Orphan Disease Network
and OD-Causing Mutant Gene Network
We defined hubs as all nodes that are in the top 20% of the degree
distribution (i.e., ODs or OD-causing mutant genes that have the
20% highest number of neighbors), whereas bottlenecks are
defined as the nodes that are in the top 20% in terms of between-
ness.27 Betweenness measures the total number of nonredundant
shortest paths going through a certain node or edge in a network,
and, combined with the degree, it is used to assess the relevance of
the location of nodes in a network.28 The degree and betweenness
centrality values are calculated with TopNet-like Yale Network
Analyzer (tYNA).29We used three well-known centralitymeasures,
namely betweenness centrality, closeness centrality, and eigen-
vector centrality (available as part of the Gephi package30) to
analyze the ODN and orphan disease-causing mutant gene
network (ODMGN). In brief, eigenvector centrality is a measure
of node importance in a network based on a node’s connections,
and closeness centrality is the average distance from a given start-
ing node to all other nodes in the network.We define a subnetwork
or a connected component as a portion of a network that consists
of nodes that are only reachable from nodes in the same network.
For all the networks constructed in this study, we determined the
number of connected components and their respective sizes by
using Gephi.30 Community or modularity, on the other, hand
represents the tightness of coupling among a specific group of
nodes in comparison to other nodes in the entire network. The756 The American Journal of Human Genetics 88, 755–766, June 10,community detection algorithm (Louvain Method31) in Gephi
was used to identify the modules in each of the networks gener-
ated in the study.
Visualization of Orphan Disease Networks
All the networks and related analyses in the current study were
performed with Gephi,30 and the results are made available as
a browseable web-based resource (Orphan Diseasome). Users can
interactively query the different networks for genes or ODs of
interest.Results
Generating and Analyzing Networks of Orphan
Diseases and Mutant Genes
We start our analysis with a curated list of 1772 ODs that
have at least one implicated gene mutation (2124 OD-
causing mutant genes or ODMGs) (Table S1, available
online). A gene and OD are considered connected if a
known mutation in that gene is implicated as a causal
mutation for the OD. Of the 1772 ODs analyzed, 1223
(~69%) have only one known gene implicated, whereas
the remaining 549 have more than one disease-causing2011
Figure 2. Network of OD Based on Shared Genes
(A) The loosely connected 184 components (subnetworks) of the ODN.
(B) One of the largest subnetworks of the ODN and the 76 modules within it. Modularity indicates the tightness of coupling among
a specific group of nodes in comparison to others in the entire network. For simplicity and clarity, only some of the nodes are labeled.
The size of the nodes is proportional to the number of other ODs that are connected to it.mutant gene. On the basis of the mutant genes currently
known to cause OD, this finding indicates that the
majority of ODs are monogenic. There are only 39 ODs
that have 10 or more known disease-causing mutant
genes. Of the 2124 OD-causing mutant genes, 1393 are
implicated in only one OD, whereas the remaining 731
genes are causative for two or more ODs. For example,
mutations of LMNA are implicated in 17 ODs, whereas
the OD nonsyndromic genetic deafness has the most
number (43) of known disease-causing mutant genes. The
average degree of 1772 ODs is 1.94 (number of disease-
causing mutant genes per OD), whereas it is 1.62 (number
of ODs per gene) for 2124 ODMGs.
The global bipartite network of ODs and ODMGs
comprises 3896 nodes (1772 ODs plus 2124 ODMGs)
and 3437 edges (gene mutations connecting ODs with
ODMGs). There are a total of 786 connected components
or subnetworks (nodes that are only reachable from nodes
in the same network), ranging in size from 734 genes and
530 ODs to just one gene and one OD. A large number
(602; ~77%) of these subnetworks comprise only one OD
and one gene. The number of communities or modules
(the tightness of coupling among a specific group of nodes
in comparison to other nodes in the network) is 1254
(Louvain modularity31 ¼ 0.81). From this OD-geneThe Amebipartite network, we first built and analyzed two types
of networks: (1) the ODN and (2) the ODMGN. Second,
we selected a subset of all ODs with four or more disease-
causing mutant genes and performed functional enrich-
ment analysis to identify enriched biological processes,
cellular components, pathways, and mammalian pheno-
type terms. We then generated a functional feature-based
orphan disease network by using shared enriched features
(Figure 1). Thus, in this network two ODs are connected
(by a shared functional feature) even if they do not share
an OD-causing mutant gene. Lastly, using the cited litera-
ture in the OD records, we constructed a document-based
OD network to analyze and compared it with the tradi-
tional gene-based OD network.
The gene-based ODN contains 1170 nodes and 2259
edges (Figure 1). In this network, each node represents an
OD, and an edge represents at least one shared ODMG.
There are 184 connected components (maximally con-
nected subgraphs) in the ODN with the largest connected
component (or subnetwork) of 530 nodes and 1396 edges
(Figure 2 and Table S2). On the other hand, the ODMGN
contains 1521 nodes and 6855 edges. In this network,
each node represents an OD-causing mutant gene, and
an edge represents at least one OD shared between two
genes (Figure 1). In case of the ODMGN, there are 183rican Journal of Human Genetics 88, 755–766, June 10, 2011 757
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connected components, and the largest connected compo-
nent has 734 nodes and 4817 edges (Figure 3 and Table S2).
There are 274 closely connected modules or communities
(modularity score 0.85) in the ODN, whereas there are
277 communities (modularity score 0.87) in the ODMGN,
suggesting important pathophysiological relatedness
between different orphan diseases and OD-causing mutant
genes (see Table S2 for a complete list of subnetworks and
communities in the orphan disease and orphan disease-
causing mutant gene networks).
To estimate the significance of connectivity in the ODN
and ODMGN, we randomly shuffled the relations between
orphan diseases and orphan disease-causing mutant genes
in the bipartite graph, whereas keeping the number of
links or edges per node (OD or ODMG) unchanged. The
average sizes of the largest connected component in
the randomized ODN and ODMGN were 954 5 18 and
1305 5 19, respectively. Both of these were significantly
larger than those of actual ODN (530) and ODMGN
(734) with both p values being less than 1.0 3 105 (one-
sample t test), respectively. Thus, clustering of ODs and
ODMGs deviates significantly from a random distribution
and is consistent with a previous study on the human
disease network9 that attributed such clustering to impor-
tant pathophysiological relatedness between different
diseases and disease genes.
Orphan Disease-Causing Mutant Gene Interactome
Genes, whose mutations cause disease, tend to be nones-
sential and show no tendency to encode hub proteins.9
To check whether genes whose mutations cause ODs are
similar to or different from common disease-causing
mutant genes, we next built the OD-causing mutant
gene interactome by using an assembled human protein
interactome. The human protein interactome used in our
study contains protein-protein interactions (PPI) from
large-scale yeast two-hybrid experiments,16,17 computa-
tional predictions,18 and curation of the literature,19–21
with both redundant interactions and self-loops removed.
The assembled PPI network consists of 12,260 proteins and
70,576 interactions. Although 1811 out of 2124 ODMGs
encode proteins that are part of human PPI network,
1488 of them interact with another protein encoded by
an ODMG and 559 interactions overlap between the
ODMGN and the orphan disease-causing mutant gene in-
teractome (ODMGI) (Table S3). Additionally, this network
of 1488 proteins of ODMGs has 3662 interactions, much
more than the expected number of 1539 interactions.
The expected number is calculated by dividing the number
of all PPIs in the PPI network (70,576) by the number of all
possible PPIs between all protein pairs (75,147,670) and
then multiplying by all possible PPIs between ODMG pairsFigure 3. Largest Subnetwork of ODMGN Based on Shared OD
This network represents the largest connected component of the O
edges (representing at least one shared OD between two OD-causing
colors). The size of the node is proportional to the number of other
The Ame(1,638,955). The 559 PPIs (representing 590 OD-causing
mutant genes for 266 ODs) that not only interact physi-
cally but also share an OD are organized as 145 connected
clusters of size 3 and larger (at least two interacting
ODMGs and an OD) of proteins implicated with the
same or a related disorder (Figure 4 and Table S3). The find-
ings and conclusions drawn from the ODMGI analyses are
presented in the following three sections.
OD-Causing Mutant Genes Have High Connectivity or Serve as
Bridges between ODMG Communities
We found that proteins encoded by OD-causing mutant
genes in the human PPI network tend to have a higher-
than-average degree (the number of edges of a node) and
betweenness centrality (the number of shortest paths
between all pairs of nodes that go through a node) when
compared to all other proteins in the network. On one
hand, about 28% (507 out of 1811) of ODMGs are hubs
in the PPI network, which is a higher percentage than
the 20% cutoff definition for all hubs (Table S4). On the
other hand, the average degree of proteins encoded by
1811 ODMGs in the PPI network (15.40) is also signifi-
cantly higher than that of other proteins in the network
(10.84) (p < 1.0 3 105; Wilcoxon rank sum test). Simi-
larly, the percentage and the average betweenness values
for ODMGs are both higher than those of all proteins in
the network (Table S4). This is in contrast to previous
studies (based on all diseases in the OMIM database) that
reported a weak correlation between hubs and disease
genes9 and that themajority of disease genes are nonessen-
tial and show no tendency to encode hub proteins.9
We next checked whether the opposite is true, that is,
whether ODMGs that are highly connected in the human
PPI network are responsible for multiple ODs. We found
that ODMGs encoding protein hubs (or bottlenecks) in
the PPI network tend to be implicated in more ODs than
nonhubs (or nonbottlenecks). The average number of
implicated ODs (the OD degree) for the 1811 ODMGs is
1.65, and there are significant differences between the
average OD degree of hubs (1.85) and nonhubs (1.58) (p ¼
0.0167 by one-sided Wilcoxon rank sum test). Similar
results are observed in comparisons of bottlenecks andnon-
bottlenecks (1.87 versus 1.56; p ¼ 4.32 3 104) (Table S5).
Protein Products of ODMGs Are More Likely to Physically Interact
with Those of Other ODMGs
For all 1811 ODMGs for which encoded protein products
are in the PPI network, the average number of interacting
partners also known to be OD-causing mutant genes is
4.04 (Table S6), and the average ratio between the
ODMG-interactant degree and the PPI degree is 0.358,
which is significantly higher than the expected ratio of
0.148 (1,810 out of 12,259) (p < 1.0 3 105; one-sample
t test). This suggests that protein products of ODMGsDMGN and has 734 nodes (OD-causing mutant genes) and 4817
mutant genes) divided into various modules (indicated by various
OD-causing mutant genes it is connected to.
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Figure 4. Interacting Genes Associated with Same or Related
OD
(A) The 559 protein-protein interactions (representing 590 orphan
disease-causing mutant genes for 266 orphan diseases) that not
only interact physically but share an OD also and are organized
as 145 connected clusters (of size 3 and larger).
(B) One of the connected clusters. The red-colored nodes are ODs,
whereas the green ones represent ODMGs. An edge between an
OD and ODMG represents known orphan disease-gene relation-
ships, whereas an edge between two genes represents a protein-
protein interaction.tend to physically interact with other protein products
of ODMGs. Although PPIs alone might not be capable
of detecting every novel OD protein, the relatively high
proportion of other OD proteins localized within the
immediate ODMG-protein interactome space is promising.
Indeed, previous studies have shown that the systematic
use of PPI data improves positional candidate gene predic-
tion by 10-fold.32
Hubs in the ODMGN Do Not Tend to Be Hubs/Bottlenecks in the
Human PPI Network
To address the question of whether an ODMG encoded
protein is a hub both in the OD and PPI network, we
next compared the ODMGN (an edge is a shared OD)
with ODMGI (an edge is PPI). Of the 1521 genes in the
ODMGN, 1302 have known protein interactions. Among
these 1302 ODMGs, 375 are hubs (the top 20% of nodes
with the highest degree values) in the human interactome,760 The American Journal of Human Genetics 88, 755–766, June 10,whereas the remaining 927 nodes are nonhubs; 388 are
bottlenecks (the top 20% of nodes with highest between-
ness centrality values), whereas the remaining 914 are
nonbottlenecks. The degree and betweenness centrality
values are calculated by tYNA.29 We found that hubs in
the ODMGN do not tend to be hubs or bottlenecks in
the human PPI network (or ODMGI). The average number
of OD-causing mutant genes that share the same ODs (the
ODMG degree) with other ODMGs in the ODMGN and are
hubs (8.28) is not significantly different from the number
that are nonhubs (9.00) in the PPI network (p ¼ 0.404;
one-sided Wilcoxon rank sum test). Furthermore, the
average ODMG degree in the ODMGN for bottlenecks in
the PPI network (8.48) is not significantly different from
that of nonbottlenecks (8.92) (p ¼ 0.544; one-sided
Wilcoxon rank sumtest) (Table S7). Therewere 220ODMGs
for which the encoded proteins do not have any known
protein interactions. These ODMGs in the ODMGN
have a higher average degree (10.34) compared to ODMGs
in the PPI network (8.79), although not statistically
significant (p ¼ 0.173) (Table S7). This implies that hub
ODMGs in ODMGN tend to be important irrespective
of their status in the PPI network. However, it should be
noted that the knowledge of the interactome remains
incomplete and that many conclusions about global
measures (e.g., network topology) should be viewed with
some skepticism.33
Orphan Disease-Causing Mutant Genes Encode
Proteins that Tend to Be Essential
To confirm our findings that OD genes tend to encode
hub or bottleneck proteins, and therefore most of them
could be essential genes, we performed a direct comparison
with essential genes as described earlier.9 About 36% (765/
2124) of the ODMGs are essential genes whose ortholog
gene knockout in mice is lethal; this is much higher than
the 22% (398/1777) of essential genes in the disease
network reported by Goh et al.9 Additionally, we have
also observed that 376 ODMGs (~18%) cause premature
deaths in mouse ortholog gene knockout models. Thus,
altogether 907 genes (~43%) from the 2124 ODMGs result
in either premature death and/or lethality in mouse gene
knockout models (Table S8). We believe that this is even
more significant and specific to ODs because Goh et al.’s
diseasome9 comprised several ODs, and the reported 22%
is probably due to the presence of some of the ODs and
genes in their dataset. To test whether this is indeed true,
we separated all ODMGs from the entire set of OMIM
disease genes (MorbidMapof theOMIM14 database), result-
ing in two classes of disease genes: 2124 ODMGs and 1901
non-ODMGs (NODMG) or commondisease genes (Figure 5
and Table S9). Although ODMGs, as defined earlier, are
genes that when mutated caused an orphan disease,
NODMGs are genes whosemutant forms are not associated
with any orphan disease (based on current orphan
disease and gene relationships in the Orphanet database).
Compared to NODMGs, ODMGs are significantly enriched2011
Figure 5. Venn Diagrams Showing the Relationships between ODMG and NODMG with Different Categories of Genes
(A) The overlap between OMIM disease genes and ODMG.
(B) The intersection of ODMG and NODMG with essential genes, whereas (C and D) show the intersections with mitochondrial genes
and genes whose knockout in mouse causes premature death.
The table in (E) shows that, compared to NODMGs, ODMGs are enriched for essentiality, mitochondrial genes, and genes associated
with premature death in the mouse knockouts.for lethality andmitochondrion, aswell as premature death
(p< 1.03 105; Fisher’s exact test) (Figure 4). A total of 765
(~36% of 2124) of ODMGs are essential, whereas only 10%
(192/1901) of NODMGs are essential. Interestingly, when
we checked the extent to which essential genes overlapped
with the entire set of disease genes fromOMIMMorbidMap
(as in Goh et al.9 but with updated disease and essential
gene lists), there were 920 (24%) essential disease genes,
which is similar to the 22% reported by Goh et al.9 This
confirms the original findings of Goh et al.,9 whose study
was based on all disease genes, still hold good despite the
increase in the database sizes of human disease genes
(from 1776 to 3864) and the essential genes (from 1267 to
2481). It also strengthens our conclusion that the enrich-
ment of essential genes is something specific to ODMGs
because the percentage of essential ODMGs is higher
when compared to either NODGMs or all disease genes
from OMIM. Additionally, these results suggest the robust-
ness of our conclusions as well as previous conclusions,9
and we do not expect them to change significantly even if
the resource databases are updated with additional genes
and annotations. To confirm our findings further, we also
repeated this analysis by focusing only on those genes
(from each category) that are in the human PPI, and we
found similar results (see Table S9 for additional details).
Of the 2124 ODMGs, 1811 (~85%) were also present in
the human protein interactome (i.e., they have at least
one interacting protein), whereas only 619 (~33%) of
1901NODMGshad at least one known interacting protein.The AmeThere was no significant difference in degree and between-
ness of ODMGs when compared to NODMGs. Although
this is surprising, one of the reasons could be the relatively
low representation (~33%) of NODMGs in the protein
interactome when compared to the representation of
ODMGs (~85%). We also intersected the ODMGs and
NODMGs with the ubiquitously expressed human genes
(UEHG)23,24 and found that ODMGs are significantly
enriched with UEHGs when compared to NODMGs (p <
1.0 3 105; Fisher’s exact test). Of the 2124 ODMGs, 863
(~41%) are UEHGs, whereas only about 13% (247/1901)
of NODMGs are UEHGs. Together, about 62% (1314/2124)
of ODMGs are essential, ubiquitously expressed, or both,
whereas in the case of NODMGs, this figure is only ~18%
(348/1901) (see Table S9 for details).
Function-Based Orphan Disease Networks
In the current study, to obtain a statistically significant and
representative functional signature from the 1772 ODs, we
first extracted all those ODs with four or more mutant
genes from our original data set. Starting with this filtered
subbipartite network of 196 ODs and 1087 genes (1283
total nodes and 1395 total edges), we built OD-OD
networks based on shared genes and shared functions.
The enriched functions (p < 0.05) for each of the 196
ODs were determined with the ToppFun application.26
The shared functions we considered for enrichment anal-
ysis included biological processes (BP) and cellular compo-
nents (CC) from Gene Ontology, KEGG pathways, andrican Journal of Human Genetics 88, 755–766, June 10, 2011 761
mammalian phenotype (MP) (Figure 1). Using the en-
riched features for each of the orphan diseases (see Table
S10 for a complete list of functional enrichment results
of the 196 ODs), we rebuilt the orphan disease networks.
However, this time the edge between two ODs represents
an enriched shared function (BP, CC, Pathway, or MP)
and not necessarily a shared gene. After generating these
function-based OD networks, we compared them with
the gene-based orphan disease networks to find the over-
lapping nodes and edges. The results were surprising.
The gene-based OD network (153 OD nodes and 191
edges; an edge indicates shared ODMG) is largely different
from various function-based OD networks, including a BP-
based OD network (176 OD nodes and 2244 edges; edges
are shared BP terms), a CC-based OD network (153 OD
nodes and 1135 edges; edges are shared CC terms), a MP-
based OD network (155 OD nodes and 745 edges; edges
are shared MP terms), and a pathway-based OD network
(159 OD nodes and 511 edges; edges are shared pathways)
(Figure 1 and Table S10). Although the node agreement
between the gene-based ODN and function-based ODNs
was higher and corresponding Jaccard indices ranged
from 0.647 to 0.732, the edge agreement was much lower,
and Jaccard indices ranged from 0.0592 to 0.162 (p< 1.03
105 compared with p for random expectations, one-
sample t test; we assessed random expectations by calcu-
lating the overlap between the gene-based network and
randomized function-based networks with shuffled edges
and unchanged node degrees). To address the effect of
data incompleteness, we added up to 20% random edges
into the gene-based and term-based networks to approxi-
mate uncovered associations and compared the overlap
of edges with what would be expected as a result of chance,
and the results are consistent (Table S10).
Literature-Based ODNs
To test the effectiveness of literature-based networks versus
traditional gene-centric approaches in identifying OD-OD
relationships, we regenerated the ODN with the edge as
a shared published article instead of a shared gene. To
avoid potential false positives, we used the corresponding
OMIM records of ODs, which summarize results from
publications about gene-disease relationships, instead of
mining literature. Specifically, we used the cited literature
(the links to PubMed records for the references cited in
an OMIM entry) in the OMIM records. For 1461 ODs there
is a corresponding OMIM record (obtained from Orpha-
net). Of the 1475 mapped OMIM records, 1370 had at least
one cited article (indicated by presence of at least one
PubMed ID). We used this subset of 1370 ODs to compare
the gene-based OD network with the literature-based OD
network.
The gene-based OD network contained 811 ODs as
nodes and 1277 edges, indicating commonODMGs shared
by a pair of ODs. The literature-based OD network
contained 747 ODs as nodes and 927 edges, representing
shared literature (PubMed IDs) for a pair of ODs. To esti-762 The American Journal of Human Genetics 88, 755–766, June 10,mate the significance of connectivity, we randomly shuf-
fled the relationships between ODs and PubMed IDs
in the bipartite graph while keeping the number of
links per OD or PubMed ID unchanged. The average size
of the largest components in the randomized ODN is
823 5 12, significantly larger than that of the actual
PubMed-based ODN (432) with a p < 1.0 3 105 by one-
sample Student’s t test. This indicates pathophysiological
clustering of ODs that deviates from a random distribution
as was seen in case of ODN and ODMGNs also.
Although a large number of common nodes exist
between the gene- and literature-based networks (517
ODs, 0.5 by Jaccard index), common edges are fewer (255
common edges, 0.13 by Jaccard index; p < 1.0 3 105
than would be expected as a result of chance, one-sample
t test; random expectations were assessed by calculating
the overlap between the gene-based network and random-
ized PubMed-based networks with shuffled edges and
unchanged node degrees). In addition, among the 517
common ODs, less than one fourth of the hubs (31 out
of 166 and 143 hubs in the gene-based and the PubMed-
based networks, respectively) are conserved. To address
the effect of data incompleteness, we randomly added up
to 20% edges into the gene-based and PubMed-based
networks to approximate uncovered associations and
compared the overlap of edges with what would have
been expected as a result of chance, and the results are
consistent (Table S11). These results indicate that the
wirings of these two networks are largely different, which
suggests that many ODs with no shared mutant genes
might still be related. We also observed that the measures
of topological importance differ significantly between the
two networks with hardly any overlap. For instance,
comparing the top 100 OD nodes (ranks are based on three
centrality measures—betweenness centrality, closeness
centrality, and eigenvector centrality) in gene-based and
literature-based networks shows very little overlap (Table
S11). Furthermore, the literature-based OD network was
able to identify additional relationships for those diseases
sharing no known disease genes but having potential func-
tional links between their corresponding disease gene sets.
Among the 927 potentially related OD pairs with literature
support, 255 (~28%) pairs also share known disease genes
and are identified by both methods. However, a large
number (672 edges; ~72%) share no known disease genes,
and their relationships are identified solely on the basis of
literature-connectivity (Figure 6 and Table S11). For
instance, Tay-Sachs disease (mutant HEXA and GM2A)
and Sandhoff syndrome (mutant HEXB) do not share any
disease genes and hence are not connected in shared-
gene-based studies.8,9 However, Tay-Sachs disease and
Sandhoff disease are connected in the literature-based
OD network, which is not surprising because these two
disorders arise because of the failure of the same metabolic
pathway. Some other examples include Rubinstein-
Taybi syndrome (CREBP and EP300mutants) and ICF syn-
drome (mutant DNMT3B), which are both syndromes of2011
Figure 6. Orphan Disease Network Based on Literature Connectivity
(A) The 577 orphan diseases (672 edges) that are connected by a shared published article. Although these diseases do not share any
common OD-causing mutant genes, they are still connected by virtue of a shared published article.
(B) A few of the literature-connected orphan diseases.chromatin modeling; ornithine transcarbamylase defi-
ciency, arginosuccinic aciduria, and citrullinemia, which
are all urea cycle disorders; Prader-Willi syndrome and
Angelman syndrome, which are both genomic-imprinting
disorders; and lathosterolosis, Smith-Lemli-Opitz syn-
drome, and Greenberg dysplasia, which are all inborn
errors of cholesterol synthesis (see Table S11 for a complete
list of subnetworks and communities in the literature-
based ODN).Discussion
Although opportunities now exist to accelerate progress
toward understanding the basis of many more orphan
diseases and for developing innovative medical ap-
proaches, relatively few efforts have successfully addressed
scientific or technical questions across a spectrum of
orphandiseases.34 Therefore, finding commongenes, path-
ways, and targets is critical if we are going to make moreThe Amethan baby steps in orphan disease research. Constructing
networks that underlie biological processes and pathways
associated with orphan diseases facilitates identification
of the functional units that respond to genetic perturba-
tions and potentially affect disease risk or therapeutic
response and can systematically move the field in a
favorable direction. We believe that the decomposition of
orphandisease networks canhelp us to understand the rela-
tionship between orphan diseases and their geneticmecha-
nisms. Studies of biological networks can identify common
pathways or processes for multiple orphan diseases that are
biologically related and comprehensive understanding
such molecular basis could provide opportunities for inter-
ventions that are beneficial for an array of related orphan
diseases. This capability could open the door for the
discovery of single therapies that canbenefitmultiple disor-
ders and also, potentially, more common diseases.34
Previous studies focusing on all diseases (from OMIM)
reported that there was a weak correlation between hubs
and disease genes9 and that the majority of disease genesrican Journal of Human Genetics 88, 755–766, June 10, 2011 763
are nonessential and show no tendency to encode hub
proteins.9 Our results, in contrast, have shown that genes
whose mutations cause orphan diseases tend to encode
proteins that are hubs, are ubiquitously expressed, and
are essential. Although we acknowledge that the partition
of disease genes into such groups (ODMG and NODMG) is
a simplification, this partition helped in gaining insights
into the relationship between the orphan disease charac-
teristics (rare, lethal, and syndromic in nature) and the
underlying causal mutant gene. First, by an evolutionary
argument, the partition could explain the rarity of orphan
diseases in a population because mutations in hubs might
not be compatible with survival and are less likely to be
maintained in a population. Second, the partition could
explain the severity and lethality associated with most of
the ODs because mutations in hubs could have wider
repercussions and larger consequences on entire system
than those in nonhubs. Additionally, functional enrich-
ment analysis of ODMGs showed that a majority result
in premature deaths or are lethal in the orthologous mouse
gene knockout models. Third, because hubs through their
multiple interacting proteins connect heterogeneous
cellular processes, the partitionmight explain the complex
phenotypic or syndromic nature of ODs that have an
impact on multiple physiological systems. The ubiquitous
nature of ODMGs might also explain this. At the same
time, the paradox of ubiquitous expression and tissue-
specific phenotypes seen in some of the orphan diseases
(e.g., IMPDH and retinitis pigmentosa) is difficult to
explain. Some of this has been explained by the existence
of novel tissue-specific isoforms and relatively high levels
of UEHGs in a particular tissue.35 Together, our results
provide further evidence that the genetic and network
properties of human genes are related and that some of
the disease characteristics can be explained by the topolog-
ical features of an individual or group of nodes in the
network.
Biological networks are known to be modular, and their
decomposition into modules or communities provides
deep insight into living systems and human diseases.36
We found high connectivity among different orphan
diseases or OD-causing mutant genes that can be used
not only to infer the common mechanism and targeted
pathways but also to find candidates for drug repositioning
or drug repurposing (i.e., to extrapolate or suggest novel
applications for already approved drugs), especially when
one or more than one orphan disease in the community
has an approved drug.
Becausemost of the previous studies elucidating relation-
ships between diseases are genecentric, they are limited in
their discovery of new and unknown disease relation-
ships.37 To address this, three recent studies12,37,38 recom-
mend using functional linkage maps. However, each of
these approaches focuses on a limited number of features,
such as gene expression and PPI data, biological processes,
or pathways to connect diseases. Although the node agree-
ment between the gene-based and function-based ODNs764 The American Journal of Human Genetics 88, 755–766, June 10,was relatively higher, the edge agreement was much lower
and indicates that their wiring is significantly different.
This suggests that the relationship between the ODs
cannot be fully captured by the gene-based networks alone.
Thus, by considering functional connectivity between
causative genes involved in different orphan diseases,
relationships between orphan diseases that are based on
underlying molecular mechanisms can be revealed. Such
associations can potentially be used to generate novel
hypotheses on the molecular mechanisms of diseases, and
can in turn guide the development of relevant therapy12
or potential drug repositioning candidates.
A literature-based discovery methodology39 was shown
to be effective in identifying disease genes. Indeed, litera-
ture-based relations between orphan diseases could
provide functional modularity and immediate insight
into the underlying molecular mechanisms and thus
generate novel hypotheses for therapeutic strategies (e.g.,
drug repositioning). In this study, we found about 670
related and diverse OD-OD relationships that are identified
only by literature connectivity but not by shared genes. To
overcome or limit the number of false positives typically
associated with text-mining exercises, we focused in the
current study only on cited literature in OD records.
However, there are some potential limitations to this
approach. For instance, we have seen examples of litera-
ture that list some of the ODs in a context other than those
relating them mechanistically or functionally.
Apart from leading to new insights into the biological
underpinnings of various ODs, we believe that our global
analysis of orphan diseasome will encourage the develop-
ment of new and innovative research on these rare condi-
tions that have been hitherto understudied. The global
analysis of all ODs can help in analyzing comorbidities
and the underlying molecular basis apart from establish-
ing potential networking opportunities. The functional
feature-based OD networks, apart from partially addressing
the limitations of the conventional gene-based connec-
tivity maps of diseases, can have direct implications to
drug discovery process. Physical protein-protein interac-
tome-based ODMGI maps can be used to generate lists of
genes potentially enriched for new candidate ODMGs.
We have also used several different types of biological
data to build functional interaction networks of ODs that
are an advantage over gene-based disease networks. These
functional interaction networks of ODs can provide
a generic framework for integrating disparate data types
into a common predictive network. Additionally, the
shared functional features between different ODs can be
mined for predicting specific OD genetic modifiers or
drug targets. Indeed, integration of various interactome
and functional relationship networks have been used
previously to predict cancer and other types of disease
susceptibility candidate andmodifier genes.40,41 An impor-
tant tool in the quest of orphan drug discovery is the ODN
that represents a genome-wide roadmap for future studies
on orphan diseasome and druggome. As such, it can be2011
used to assess interactions between orphan diseases and
the disease-causing mutant genes through the orphan dis-
easome web site that we have made available online and
that offers global perspective and a rapid visual reference
of the genetic links between orphan diseases and mutant
genes. For instance, overlaying the network of ODs and/or
genes with orphan drugs or common disease drugs can be
used as a discovery platform for identifying potential drug
repositioning candidates.Supplemental Data
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